TRV GP IV, LLC — Q3 2025 13F-HR

← TRV GP IV, LLC

Q3 2025 · 13F-HR

TRV GP IV, LLCholdings as filed

Filed 2025-11-13 · accession 0001193125-25-280198

$274.0M

Reported value

Positions

2025-09-30

Period end

View analyzed profile →PRO

The Brief · TRV GP IV, LLC · Q3 2025

AI · grounded in 13F

TRV GP IV, LLC established a new position in MAZE valued at $157.5M. The fund also initiated a new position in TNGX totaling $116.5M. These two holdings comprise the fund's total assets under management of $273.9M.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
578784100	MAZE	MAZE THERAPEUTICS, INC.	$157.5M	57.5%	6,073,958	Common	SOLE
87583X109	TNGX	TANGO THERAPEUTICS, INC.	$116.5M	42.5%	13,863,975	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.